Suchergebnisse - "Dienstmann, R."

PubPharm (51)

1

ESMO Guidance for Reporting Oncology real-World evidence (GROW)

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2023

von Castelo-Branco, L. | Pellat, A. | Martins-Branco, D. | +20

2

Time to start testing KRAS and BRAF V600E mutations in stage III colon cancer? Not in routine care, yet in clinical trials

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2023

von Dienstmann, R.

3

Establishment of patient-derived tumor organoids to functionally inform treatment decisions in metastatic colorectal cancer

enthalten in: ESMO open | 2023

von Martini, G. | Belli, V. | Napolitano, S. | +30

4

Association of RAD51 with homologous recombination deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC) : analysis of the GeparSixto randomized clinical trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2021

von Llop-Guevara, A. | Loibl, S. | Villacampa, G. | +18

5

Association of RAD51 with homologous recombination deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC) : analysis of the GeparSixto randomized clinical trial

enthalten in: Annals of oncology | 11 September 2021

von Llop-Guevara, A. | Loibl, S. | Villacampa, G. | +18

6

Genomic testing for targeted oncology drugs : hopes against hype

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2021

von Dienstmann, R. | Tamborero, D.

CommentOn: Ann Oncol. 2021 Jul;32(7):926-932. - PMID 33862157

7

Impact of COVID-19 on social media as perceived by the oncology community : results from a survey in collaboration with the European Society for Medical Oncology (ESMO) and the OncoAlert Network

enthalten in: ESMO open | 2021

von Morgan, G. | Tagliamento, M. | Lambertini, M. | +15

8

Dynamics of clinical biomarkers as predictors of immunotherapy benefit in metastatic melanoma patients

enthalten in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2021

von Hernando-Calvo, A. | García-Alvarez, A. | Villacampa, G. | +6

9

Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers : a report from the ESMO Precision Medicine Working Group

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2020

von Mosele, F. | Remon, J. | Mateo, J. | +19

10

Fusobacterium nucleatum persistence and risk of recurrence after preoperative treatment in locally advanced rectal cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2020

von Serna, G. | Ruiz-Pace, F. | Hernando, J. | +11

CommentIn: Ann Oncol. 2020 Oct;31(10):1277-1278. - PMID 32629022

1
2
3
4
5
6
Nächster »
[6]